From
StayCurrentMD
Reply to Letter to the Editor
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Oct 2019 · 1 min read
In brief
In brief
Response to correspondence regarding a 26-year single-center study on hepatoportoenterostomy (HPE) outcomes in biliary atresia patients. The authors reaffirm that total bilirubin at 3 months post-HPE is the strongest predictor of progression to liver transplantation, consistent with prior multicenter findings.
Written by the GCMD Library team from the article.
We appreciate the letter from Dr. Davenport and Dr. Macdonald from Kings College Hospital regarding our single center 26-year experience and long-term outcomes for patients who underwent HPE for biliary atresia. The aim of our study was to determine perioperative risk factors associated with progression to liver transplantation following HPE [1]. Our results, similar to those of Shneider et.al [2], showed total bilirubin at 3 months following HPE was the strongest predictor of need for transplantation.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Intestinal Atresia Types Explained: Grossfeld Classification for Pediatric Surgery
1 min · Published Sep 2026
Video
Derivation and validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) score: A prospective cohort study
50 s · Published Sep 2026
Video
FETO for Late-Diagnosed Severe Congenital Diaphragmatic Hernia (CDH) at Cincinnati Children's with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Severe Congenital Diaphragmatic Hernia (CDH) Case: FETO Management & Unexpected Findings with Dr. Beth Rymeski
3 min · Published Sep 2026
Video
Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure: Step-by-Step Guide with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Choledochal Cyst Types Explained: Pediatric Surgery Fundamentals
1 min · Published Sep 2026